Pharmagreen Biotech Ownership

PHBI Stock  USD 0  0.0002  16.67%   
Pharmagreen Biotech owns a total of 454.76 Million outstanding shares. Pharmagreen Biotech holds 18.63 pct. of its outstanding shares held by insiders and 0.0 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Pharmagreen Biotech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pharmagreen Biotech, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagreen Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Pharmagreen Pink Sheet Ownership Analysis

About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Pharmagreen Biotech last dividend was issued on the 2nd of July 2018. The entity had 1:200 split on the 2nd of July 2018. Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.The quote for Pharmagreen Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Pharmagreen Biotech contact Peter BA at 702-803-9404 or learn more at https://www.pharmagreen.ca.

Currently Active Assets on Macroaxis

Other Information on Investing in Pharmagreen Pink Sheet

Pharmagreen Biotech financial ratios help investors to determine whether Pharmagreen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagreen with respect to the benefits of owning Pharmagreen Biotech security.